Contact this trialFirst, we need to learn more about you.
Janus Kinase (JAK) Inhibitor
Ruxolitinib for Bronchiolitis Obliterans Syndrome
Recruiting3 awardsPhase 2
Boston, Massachusetts
This trial is testing a drug to see if it can treat BOS, a condition that may occur after HCT, a procedure where blood cells are transplanted from one person to another.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service